The DOI matches its Crossref record.
Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.
Open accessAbstract
We initiated the present study to evaluate the clinical value of consecutive concentration determinations of S-100 and glial fibrillary acidic proteins in cerebrospinal fluid from patients with brain infarction. We took sequential samples of cerebrospinal fluid from 28 patients within 48 hours, at 7 days, and at 18-21 days after the ictus. We measured astroglial protein concentrations using an enzyme-linked immunosorbent assay and also determined size of the infarction (computed tomography), clinical state of the patient (simplified activities of daily living test), blood-brain barrier dysfunction (cerebrospinal fluid/serum albumin ratio), and a myelin marker (myelin basic protein). We found a transient increase of both proteins in the cerebrospinal fluid during the first week after the ischemic stroke (p less than 0.05). This increment was significantly correlated with the size of the infarction and the clinical state of the patients. Transient release of astroglial proteins into the cerebrospinal fluid possibly reflects initial focal ischemic damage and, in the later phase, ongoing destruction of astroglial cells in the penumbra zone. We suggest that determinations of cerebrospinal fluid astroglial protein concentrations can be used to estimate ischemic brain damage, which should be of particular value in clinical trials of pharmacological agents, such as calcium antagonists, on stroke patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
S100B in brain damage and neurodegeneration
Rothermundt, M., Peters, M., Prehn, J. H. M., & Arolt, V. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10303 · Cited by 609
Fatty acid-binding proteins as plasma markers of tissue injury
Pelsers, M. M. A. L., Hermens, W. T., & Glatz, J. F. C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.001 · Cited by 488
Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997) · Stroke · doi:10.1161/01.str.28.10.1956 · Cited by 456
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury
Vos, P. E., Lamers, K. J. B., Hendriks, J. C. M., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J., & Verbeek, M. M. (2004) · Neurology · doi:10.1212/01.wnl.0000120550.00643.dc · Cited by 412
Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H. M. M., & Lamers, K. J. B. (2000) · Stroke · doi:10.1161/01.str.31.11.2670 · Cited by 400
Elevated neurofilament levels in neurological diseases
Norgren, N., Rosengren, L., & Stigbrand, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03219-0 · Cited by 351
Self-citationSnygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588663 · Cited by 320
“Levels of GFAP are known to increase in CSF in response to a variety of neurological disorders associated with cerebral damage, including stroke, and levels correlate with the severity of the injury [26, 27].”
BackgroundSelf-citationNeurofilament light protein and glial fibrillary acidic protein as biological markers in MS
Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318
Self-citationS-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction
Büttner, T., Weyers, S., Postert, T., Sprengelmeyer, R., & Kuhn, W. (1997) · Stroke · doi:10.1161/01.str.28.10.1961 · Cited by 259
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Rosengren, L. E., Wikkelsø, C., & Hagberg, L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90011-6 · Cited by 256
Self-citationLamers, K. J. B., Vos, P., Verbeek, M. M., Rosmalen, F., van Geel, W. J. A., & van Engelen, B. G. M. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00089-3 · Cited by 138
Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections
Grahn, A., Hagberg, L., Nilsson, S., Blennow, K., Zetterberg, H., & Studahl, M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6883-5 · Cited by 67
Metadata
- Authors
- Aurell, A., Rosengren, L. E., Karlsson, B., Olsson, J. E., Zbornikova, V, & Haglid, K. G.
- Venue
- Stroke
- Published
- 1991-10
- Volume
- 22
- Issue
- 10
- Pages
- 1254-1258
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2076855848
- Cited by
- 210
- References
- 0
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.